Pdt Partners, LLC Revolution Medicines, Inc. Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $345,323 - $514,228	19,778 New	19,778 $390,000
Q2 2022 Aug 15, 2022	SELL	$14.54 - $27.17 $183,262 - $342,450	-12,604 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $218,175 - $332,745	12,604 New	12,604 $322,000
Q1 2021 May 17, 2021	SELL	$37.21 - $54.43 $441,050 - $645,158	-11,853 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$30.19 - $45.49 $357,842 - $539,192	11,853 New	11,853 $469,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.